Table 1.
Stages | Treatments guidelines |
---|---|
At risk category: no apparent exposed/necrotic bone in patients treated with either oral or iv bisphosphonates | No treatment indicated |
Patients education | |
Stage 1: exposed/necrotic bone in patients who are asymptomatic and have no evidence of infection | Antibacterial mouth rinse |
Clinical follow-up every 4 months | |
Stage 2: exposed/necrotic bone associated with infection. Presence of pain and erythema in the lesional area with or without purulent drainage | Treatment with broad-spectrum oral antibioticsb |
Antibacterial mouth rinse | |
Pain control | |
Superficial debridement to relieve soft tissue irritation | |
Stage 3: exposed/necrotic bone in patients with infection and pain. Presence of one or more of the following: pathologic fractures, extraoral fistula, or osteolysis extending to the inferior border | Antibacterial mouth rinse |
Antibiotic therapy and pain control | |
Surgical debridement/resection for longer term palliation of infection and pain |
aModified from Ref. [53]
bPenicillin, amoxicillin/clavulanate potassium, metronidazole, cephalexin, clindamycin, fluoroquinolone